Narrow search
Showing 1 - 6 of 6
Cover Image
Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries
Gulácsi, László; Rencz, Fanni; Péntek, Márta; … - In: The European journal of health economics : HEPAC ; … 15 (2014), pp. 27-34
Persistent link: https://www.econbiz.de/10010376453
Cover Image
Towards a Central-Eastern European EQ-5D-3L population norm : comparing data from Hungarian, Polish and Slovenian population studies
Zrubka, Zsombor; Golicki, Dominik; Prevolnik Rupel, … - In: The European journal of health economics : HEPAC ; … 20 (2019), pp. S141-S154
Persistent link: https://www.econbiz.de/10012060949
Cover Image
Cost-of-illness studies in nine Central and Eastern European countries
Brodszky, Valentin; Beretzky, Zsuzsanna; Baji, Petra; … - In: The European journal of health economics : HEPAC ; … 20 (2019), pp. S155-S172
Persistent link: https://www.econbiz.de/10012060954
Cover Image
Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries
Brodszky, Valentin; Baji, Petra; Balogh, Orsolya; … - In: The European journal of health economics : HEPAC ; … 15 (2014), pp. 65-71
Persistent link: https://www.econbiz.de/10010377073
Cover Image
Biological therapy in inflammatory rheumatic diseases : issues in Central and Eastern European countries
Péntek, Márta; Poór, Gyula; Wiland, Piotr; … - In: The European journal of health economics : HEPAC ; … 15 (2014), pp. 35-43
Persistent link: https://www.econbiz.de/10010376418
Cover Image
Health economics and health technology assessment in Central and Eastern Europe : a dose of reality
Gulácsi, László; Orlewska, E.; Péntek, M. - In: The European journal of health economics : HEPAC ; … 13 (2012) 5, pp. 525-531
Persistent link: https://www.econbiz.de/10009657379